Piracetam
Values approved
0/22 (0%)
Data points an editor reviewed and accepted for publication.
01
Value Provenance
Dosing
oral
Predates provenance tracking — no derivation record for this dataset
| Field | Published | AI Proposed | Confidence |
|---|---|---|---|
| Threshold | 0.25 g | no record | |
| Low | 0.5–2 g | no record | |
| Common | 2–3 g | no record | |
| Strong | 3–5 g | no record | |
| Heavy | 5+ g | no record |
Duration
oral
Predates provenance tracking — no derivation record for this dataset
| Field | Published | AI Proposed | Confidence |
|---|---|---|---|
| Onset | 30–90 minutes | no record | |
| Total | 4–8 hours | no record |
Safety
Toxicity Profile
Predates provenance tracking — no derivation record for this dataset
| Field | Published | AI Proposed | Confidence |
|---|---|---|---|
| Acute | low | no record | |
| Chronic | low | no record | |
| Organs Affected | — | no record |
Dependence Profile
Predates provenance tracking — no derivation record for this dataset
| Field | Published | AI Proposed | Confidence |
|---|---|---|---|
| Physical | none | no record | |
| Psychological | none | no record | |
| Compulsive Redosing | — | no record | |
| Dose Escalation | — | no record |
Tolerance Profile
Predates provenance tracking — no derivation record for this dataset
| Field | Published | AI Proposed | Confidence |
|---|---|---|---|
| Buildup | develops with prolonged and repeated use | no record | |
| Half-life | 5 days | no record | |
| Full Reset | 1.5 weeks | no record | |
| Cross-tolerances | racetam, nootropic | no record |
02
History
current version
published —human-authored—
versions
1 total
publication ledger
backfill Mar 17, 2026
Historical versions do not record which reviewer approved them; editorial accountability is recorded per value in the database and in the publication ledger going forward.
03
Sources
No bibliography recorded — this version predates provenance tracking.
04
Claim Verification
No claim verification has run for this version.
05
Coverage & Gaps
effect links
16 links · 0 approved · 0 audited16/16 with evidence basis